Motzer, Robert J ;
Escudier, Bernard ;
McDermott, David F...
Motzer , R J , Escudier , B , McDermott , D F , Arén Frontera , O , Melichar , B , Powles , T , Donskov , F , Plimack , E R , Barthélémy , P , Hammers , H J , George , S , Grünwald , V , Porta , C , Neiman , V , Ravaud , A , Choueiri , T K , Rini , B I , Salman , P , Kollmannsberger , C K , Tykodi , S S , Grimm , M O , Gurney , H , Leibowitz-Amit , R , Geertsen , P F , Amin , A , Tomita , Y , McHenry , M B , Saggi , S S & Tannir , N M 2020 , ' Survival outcomes and independent response assessment with nivolumab plus ipilimumab versus sunitinib in patients with advanced renal cell carcinoma : 42-month follow-up of a randomized phase 3 clinical trial ' , Journal for ImmunoTherapy of Cancer , vol. 8 , no. 2 , e000891 , pp. 1-12 . https://doi.org/10.1136/jitc-2020-000891.
,
2020
